These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 2510274
1. Drug safety of rioprostil in patients with active gastric or duodenal ulcer. Corsing C, Demol P. Scand J Gastroenterol Suppl; 1989; 164():232-7; discussion 237-8. PubMed ID: 2510274 [Abstract] [Full Text] [Related]
2. Efficacy and safety of rioprostil, 300 micrograms b.d., in the treatment of duodenal ulcer: a double-blind, controlled multicentre clinical study vs. ranitidine. Coremans G, Vantrappen G, Businger JA, Demol P. Scand J Gastroenterol Suppl; 1989; 164():198-205; discussion 205-6. PubMed ID: 2510268 [Abstract] [Full Text] [Related]
3. Rioprostil vs. ranitidine in duodenal ulcer healing: a double-blind multicentre trial. Lavignolle A, Raillat A, Slama JL, Viteau JM, Veyres B, Lebourgeois P, Audigier JC, Abgrall J, Parlier H, Vray M. Scand J Gastroenterol Suppl; 1989; 164():194-7. PubMed ID: 2510267 [Abstract] [Full Text] [Related]
4. Treatment of benign gastric ulcer: a comparative clinical trial of rioprostil and ranitidine. Quinton A, Goldfain D, Weber F, Briaud M, Plane D, Bancons J, Monneris R, Audigier JC, Arnal JC, Lacoste D. Scand J Gastroenterol Suppl; 1989; 164():178-82; discussion 182-3. PubMed ID: 2510264 [Abstract] [Full Text] [Related]
5. Rioprostil, a new prostaglandin E1 analogue, in the once-daily treatment for the prevention of duodenal ulcer recurrence: a comparison with ranitidine. Businger JA, Fumagalli I, Michel H, Delas N, Stocker H. Scand J Gastroenterol Suppl; 1989; 164():152-9; discussion 159-60. PubMed ID: 2510260 [Abstract] [Full Text] [Related]
6. Rioprostil and ranitidine in the prevention of duodenal ulcer relapse. Rampal P, Raillat A, Viteau JM, Slama JL, Lavignolle A, Bedenne L, Veyres B, Toulet J, Vray M, Prunieras F. Scand J Gastroenterol Suppl; 1989; 164():146-50; discussion 150-1. PubMed ID: 2510259 [Abstract] [Full Text] [Related]
7. Rioprostil, a new prostaglandin E1 analogue, in the once-daily treatment of acute duodenal ulcer: a comparison with ranitidine. Businger JA, Miglio F, Gasbarrini T, Vismans FJ, Geraedts AA, Stocker H. Scand J Gastroenterol Suppl; 1989; 164():161-7; discussion 167-8. PubMed ID: 2510261 [Abstract] [Full Text] [Related]
8. Efficacy and safety of rioprostil, 300 micrograms b.d., in the treatment of gastric ulcer: a comparison vs. ranitidine, 150 mg b.d., in a randomized multicentre study. Rutgeerts P, Vantrappen G, Businger JA, Demol P, Simon B, Barbier P. Scand J Gastroenterol Suppl; 1989; 164():184-90. PubMed ID: 2510265 [Abstract] [Full Text] [Related]
9. Side effects of anti-ulcer prostaglandins: an overview of the worldwide clinical experience. Bianchi Porro G, Parente F. Scand J Gastroenterol Suppl; 1989; 164():224-9; discussion 229-31. PubMed ID: 2510273 [Abstract] [Full Text] [Related]
10. Treatment of duodenal ulcer with rioprostil: a randomized multicentre double-blind study. Boucekkine T, Meknini B, Bitoun A, Prunièras F, Khedis A, de Lauture D, Rotenberg A, Molinie C, Roux M, Gauthier A. Scand J Gastroenterol Suppl; 1989; 164():191-3. PubMed ID: 2510266 [Abstract] [Full Text] [Related]
11. Rioprostil in the healing of duodenal ulceration: a short report. Whorwell PJ. Scand J Gastroenterol Suppl; 1989; 164():214. PubMed ID: 2510270 [Abstract] [Full Text] [Related]
12. A single evening dose of rioprostil, 600 micrograms, in the treatment of acute duodenal ulcers. Dammann HG, Dreyer M, Müller P, Simon B, Demol P. Scand J Gastroenterol Suppl; 1989; 164():215-8. PubMed ID: 2510271 [Abstract] [Full Text] [Related]
13. Effect of rioprostil on the gastric acid and bicarbonate secretion in patients with gastric ulcer. Krastev Z, Deredjian S, Matincheva R, Spasova Z, Karakasheva V. Scand J Gastroenterol Suppl; 1989; 164():141-5. PubMed ID: 2510258 [Abstract] [Full Text] [Related]
14. [Therapeutic use of rioprostil, 600 micrograms o.d., in duodenal peptic ulcer during its active uncomplicated phase]. Benvestito V, Benvestito S, Guida M, Mariani L. Minerva Dietol Gastroenterol; 1988; 34(3):191-5. PubMed ID: 3143950 [No Abstract] [Full Text] [Related]
15. Rioprostil in the short-term treatment of duodenal ulcer: a multicentre double-blind trial vs. cimetidine. Bianchi Porro G, Parente F, Hentschel E, Bennani A, Sebti F, Cherkaoui A, Demyttenaere M, Gouerou H, Blasi A, Darnis F. Scand J Gastroenterol Suppl; 1989; 164():219-23. PubMed ID: 2510272 [Abstract] [Full Text] [Related]
16. Rioprostil in the acute and long-term treatment of peptic ulcers: a review. Dammann HG, Dreyer M, Müller P, Simon B. Scand J Gastroenterol Suppl; 1989; 164():207-11; discussion 212-3. PubMed ID: 2510269 [Abstract] [Full Text] [Related]
17. Rioprostil: a new prostaglandin for treatment of peptic ulcer disease and NSAID-induced digestive lesions. Proceedings of an international symposium. Wiesbaden, 11-13 June 1987. Scand J Gastroenterol Suppl; 1989; 164():1-253. PubMed ID: 2510250 [No Abstract] [Full Text] [Related]
18. Rioprostil 600 micrograms nocte: high duodenal ulcer healing rates, low incidence of side effects. Dammann HG, Dreyer M, Walter TA, Müller P, Simon B. Prog Clin Biol Res; 1987; 242():289-93. PubMed ID: 3118383 [No Abstract] [Full Text] [Related]
19. Rioprostil in the treatment of duodenal erosions. Guslandi M, Ballarin E, Tittobello A. Scand J Gastroenterol Suppl; 1989; 164():174-6; discussion 176-7. PubMed ID: 2510263 [Abstract] [Full Text] [Related]
20. Prostaglandins and peptic ulcer disease: nocturnal administration of rioprostil vs ranitidine in duodenal ulcer healing. Simon B, Dammann HG, Müller P. Klin Wochenschr; 1986; 64 Suppl 7():44-6. PubMed ID: 3104657 [Abstract] [Full Text] [Related] Page: [Next] [New Search]